SENSUS HEALTHCARE, INC.

Analyst Reco. Sensus Healthcare, Inc.

Equities

SRTS

US81728J1097

Market Closed - Nasdaq Other stock markets 21:00:00 15/05/2024 BST			5-day change	1st Jan Change
6.14 ^USD	+15.85%		+60.31%	+160.17%

05-10	Top MIdday Gainers	MT
05-10	Wall Street Set to Extend Gains on Thursday's Higher-Than-Expect Jobless Claims Report, Lifting US Equity Futures Pre-Bell	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Price Target on Sensus Healthcare to $8 From $10, Keeps Buy Rating	07/08/23	MT
Alliance Global Adjusts Sensus Healthcare's Price Target to $7 From $14.50, Keeps Buy Rating	04/05/23	MT
Alliance Global Partners Adjusts Sensus Healthcare Price Target to $14.50 From $16.50, Maintains Buy Rating	10/02/23	MT
Alliance Global Partners Adjusts Price Target on Sensus Healthcare to $16.50 From $17.50, Maintains Buy Rating	04/11/22	MT
HC Wainwright Adjusts Sensus Healthcare's Price Target to $13 From $12, Reiterates Buy Rating	03/03/22	MT
HC Wainwright Lifts Sensus Healthcare Price Target to $12 From $10, Maintains Buy Rating	14/02/22	MT
HC Wainwright Adjusts Price Target on Sensus Healthcare to $10 From $9, Maintains Buy Rating	02/12/21	MT
HC Wainwright Adjusts Price Target on Sensus Healthcare to $9 From $7, Maintains Buy Rating	05/11/21	MT
SENSUS HEALTHCARE : HC Wainwright & Co. Adjusts Price Target on Sensus Healthcare to $6 From $4, Maintains Buy Rating	01/03/21	MT
DJ Industrial : Stocks Mixed in Choppy Midday as Tightening Rates Weigh	26/02/21	MT
Midday Report: Wall Street Mixed in Choppy Midday as Tightening Rates Weigh	26/02/21	MT
SENSUS HEALTHCARE : Roth Capital Adjusts Price Target on Sensus Healthcare to $6 From $4, Maintains Buy Rating	26/02/21	MT
SENSUS HEALTHCARE : Northland Downgrades Sensus Healthcare to Market Perform From Outperform	16/12/20	MT
SENSUS HEALTHCARE : HC Wainwright Adjusts Price Target on Sensus Healthcare to $4 From $5, Reiterates Buy Rating	09/11/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer